All In Biotech

Drug Trial Radar · NCT04370236

INB03 for the Treatment of Pulmonary Complications From COVID-19

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of INB03 in the Treatment of Participants With Pulmonary Complications From Coronavirus Disease (COVID-19)

Last checked: Nov 19, 2026Latest source record: May 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

79

Actual

Start

Oct 21, 2020

Primary completion

Oct 13, 2021

Study completion Nov 18, 2021

Sponsor

Lead sponsor
Inmune Bio, Inc.Industry
Sponsor type
Industry
First posted
Apr 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether XPro1595 can prevent the progression of respiratory complications in COVID19 patients.

Conditions

  • COVID-19

Interventions

  • INB03Drug

    Patients will receive up to two once per week subcutaneous injections of 1mg/kg INB03

  • PlaceboDrug

    Patients will receive up to two once per week subcutaneous injections of Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cochran-Mantel-Haenszel Analysis of Proportion of Patients With Disease ProgressionTime frame: 28 days

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • NEA Baptist

    Jonesboro, Arkansas

  • St. Bernard's

    Jonesboro, Arkansas

  • Jewish Hospital

    Louisville, Kentucky

  • Mississippi Baptist

    Kosciusko, Mississippi

  • Baptist Memorial Hospital-DeSoto

    Southard, Missouri

  • Richmond University Medical Center

    Staten Island, New York

  • Baptist Clinical Research Institute

    Memphis, Tennessee

  • Memorial Hermann

    Houston, Texas

  • Memorial Hermann Southeast

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.